Households exposed to COVID-19 now have an oral drug specifically cleared to prevent infection after contact with a sick person. The FDA listed Xocova, the brand name for ensitrelvir, as a 2026 novel ...

Add Yahoo as a preferred source to see more of our stories on Google. Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common ...

You have limited options right now if you know you’ve been exposed to COVID-19. There used to be monoclonal antibody treatments available, but those were given through an IV, and the Food and Drug ...

To first understand how to stop a pandemic, or at least mitigate it, you first have to understand what an outbreak is. “An ...

An experimental oral medication can dramatically lower the risk of getting COVID-19 after an exposure. The new pill, Ensitrelvir, is already approved for use in Japan. Infectious disease experts are ...

In late June, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), a group of independent experts convened by the World Health Organization (WHO), published an assessment of the ...

The Centers for Disease Control and Prevention said on Tuesday that it is likely that the spread of coronavirus will reach pandemic levels, as scientists still are trying to solve how to stop the ...

HOUSTON, Texas -- With COVID-19 cases in the U.S. surpassing 250,000 by early April, health officials are still recommending basic hygiene tips to limit the spread of the virus. Experts say one of the ...

Five years ago, COVID was all we could think about. Today, we'd rather forget about lockdowns, testing lines and social distancing. But the virus that sparked the pandemic, SARS-CoV-2, is still ...

Share on Pinterest Could GLP-1s hold the key to protecting people with diabetes against long COVID? Image credit: Jon Challicom/ Getty Images Some people develop long COVID after a SARS-CoV-2 ...